Background: Rigorous antimicrobial stewardship programmes (ASPs) are an essential strategy against antimicrobial resistance.
Introduction
Antimicrobial resistance due to inappropriate or excessive antimicrobial use is a significant public health concern.
1 Optimizing prescribing practice through antimicrobial stewardship programmes (ASPs) is one of the seven key areas outlined in the UK Five Year Antimicrobial Resistance Strategy 2013-18 and implementation of stewardship practice is legally mandated by the Department of Health and Social Care. 1, 2 In England, acute inpatient hospital services are managed by NHS trusts. An NHS trust may have oversight of a single hospital or a combination of acute secondary, specialist and/or tertiary level hospitals. Whilst national and international guidelines on how to develop and implement stewardship programmes exist, practices vary across trusts and within trusts based on the type of hospital across the country. [3] [4] [5] [6] [7] [8] For the purposes of this study the term 'hospital' reflects one or more hospitals within a trust.
Assessing the effectiveness of an ASP is difficult due to the lack of easily measurable outcomes. For this reason, much of the research to date concentrates on hospital antimicrobial usage data or economic parameters as surrogate outcome measures. 9 ,10 Very few methods have been validated; however, toolkits and scoring systems for evaluating ASPs have been described. 4, [10] [11] [12] [13] [14] [15] Antimicrobial usage data in England are submitted by NHS hospitals via their trust as part of Commissioning for Quality and Innovation for Antimicrobial Resistance (CQUIN AMR). The NHS CQUIN AMR 2016/17 describes targets for NHS trusts. These are financially linked initiatives introduced to reduce the use of specific 'critical' broad-spectrum antimicrobials (including carbapenems and piperacillin/tazobactam) and total antimicrobial consumption by at least 1% per year in secondary care. 7, 16 The aim of this study was to evaluate ASPs in hospitals in England, to score the programme based on whether a quality indicator was resource and labour light or intensive and to evaluate ASPs based on these metrics against total antibiotic prescribing and prescribing within the AWaRe (Access, Watch and Reserve) categories [from the WHO Essential Medicines List (EML) 17 and modified for England] as an outcome measure.
To our knowledge this is the first study to utilize AWaRe prescribing as an outcome measure for ASPs.
Materials and methods
An online survey containing 34 questions, based on national and international guidance 3, 4, 6, 8 addressing specific components of an ASP, was sent to acute NHS hospitals in England between June and October 2017. The questionnaire was piloted by four NHS infection specialists from three different NHS hospitals and validated for clarity and relevance. Feedback from the pilot was used to improve the final questionnaire (Questionnaire S1, available as Supplementary data at JAC Online).
The questionnaire broadly addressed quality indicators relating to structure and process of an ASP as described in Table 1 . 4, 6, 8, 9 The questionnaire consisted of a series of closed questions (with the opportunity for free-text comments). The dedicated person(s) responsible for stewardship in each hospital was asked to complete the questionnaire. If a trust contained multiple hospital sites with the same programme, only one response was required.
NHS hospitals were divided into three categories for analysis: teaching (secondary and tertiary level facilities that are recognized centres for undergraduate and postgraduate medical education), specialist (delivering specialty-specific tertiary level care, some of which also provide postgraduate training) or non-teaching (secondary level care). Hospitals were also categorized by geographical region as shown in Figure 1 .
A scoring system was constructed based on existing published scoring systems and expert panel review. 5, 12, 14 A score ranging from 0 (lowest score, reflecting the most basic programme components likely to be embedded in most trusts) to 3 was assigned to key structure and process questions depending on the resources (financial and labour) required to achieve that quality indicator (Questionnaire S2), with respondents demonstrating adherence to more ASP components achieving higher scores. The total and grouped (structure and process) category scores were then used for comparative analysis.
Antimicrobial usage data were submitted to PHE as part of the NHS England CQUIN AMR i.e. total antimicrobial usage and usage of antimicrobials according to an amended WHO AWaRe categorization of antimicrobial agents (amended by the Department of Health and Social Care advisory committee on Antibiotic Prescribing, Resistance and Healthcare-Associated Infections). Antibiotic consumption data expressed as DDD per 1000 hospital admissions were used as an outcome measure. NHS England designated 2016 as the baseline year for analysis as this was the first year of standardized quarterly CQUIN AMR data collection. Although piperacillin/tazobactam usage data were collected for 2016 and 2017, due to global supply shortages during 2017 these data were excluded from the analysis.
Of 154 acute NHS hospitals, 153 were approached to complete the survey; one tertiary ophthalmology hospital was excluded as microbiology and stewardship services were provided by an associated hospital. Two hospital management trusts were undergoing a merger leaving 152 in total. All hospitals that submitted CQUIN AMR data (78% of hospitals surveyed for the ASP programme) were included in the outcome analysis.
Statistical analysis
Linear regression was used to determine the relationship between stewardship structure and process scores, and differences in stewardship scores by geographical region and hospital type. Random effects Poisson models were fitted to determine changes in total antimicrobial usage and carbapenem usage rates from 2016 to 2017, allowing for random variation in the baseline rate and the trend by trust. A logistic regression model of similar structure was fitted to the proportion of 'Watch' and 'Reserve' antimicrobials used of the total DDD. The 'Access' category comprises 99.9% of the remainder of the DDD and is therefore nearly determined by the other two outcomes. Results were expressed as incidence rate ratios (IRRs) and ORs.
Further analyses using Poisson and logistic regression were performed to assess the relationship between ASP structure and process scores with antimicrobial usage. Scores were dichotomized, based on the medians of the range of scores, to low (, 15 and ,30) or high (15 and 30) for structure and process, respectively. Rates of overall prescribing, or proportions of 'Watch/Reserve' of DDD, were compared between trusts with high versus low structure and process scores and IRRs or ORs calculated as appropriate. Differences in baseline rate according to hospital type were accounted for, but not differences in trends, so as to not complicate the interpretation of trend effects according to score.
Results
The questionnaire response rate was 97% (148/152). Duplicate responses were merged; if discrepancies were noted, the original respondents were contacted and asked to provide a consensus and answers were modified accordingly. Specialist (13/148) and teaching (33/148) hospitals accounted for 31% of the total surveyed; the remainder were non-teaching hospitals (102/148, 69%). CQUIN AMR data for both 2016 and 2017 were submitted by 116 (78%) hospitals.
Structure and process
Areas of ASP structure where the majority (over 80%) of hospitals achieved high scores included antimicrobial policies, stewardship team structure, designated stewardship leads and antimicrobial pharmacists, and access to outpatient parenteral antimicrobial therapy (OPAT) services, as shown in Table 1 . Weaker structure components (where ,50% of hospitals had measures in place) included senior clinical leadership support and dedicated programme funding.
High process performance (.80% of hospitals) was observed for pre-authorization strategies, antimicrobial review and feedback, restricted reporting of antimicrobial susceptibility test results to the clinical team, monitoring adherence to guidelines and policies, antimicrobial consumption monitoring and provision of training to junior doctors. The process interventions that were performed in ,50% of hospitals included distribution of resistance surveillance data reports and education of senior clinicians or other prescribers.
The majority of hospitals (85%; 126/148) restricted access to specific antimicrobials as shown in Figure 2 . With the exception of Scobie et al. In just over half of hospitals (58%, 73/126), pre-authorization was required before the first dose. In 26 (21%) trusts, pre-authorization was mandatory before the second and subsequent doses; and in 25 (20%), pre-authorization was only required during working hours (9am to 5pm on weekdays). If pre-authorization was required outside of routine working hours, the most common mechanism was via the on-call microbiologist (71%, 90/126). In a proportion of trusts (48%, 61/126), at least one clinical unit was exempt from pre-authorization: most commonly the ICU in 49% (30/61) of hospitals and haematology units (46%; 28/61). In 23% (34/148) of hospitals, stewardship ward rounds were conducted daily (including weekends) in one or more selected areas in the hospital, followed by three times weekly in 19%, twice weekly (6%) and weekly (1%). Regular stewardship ward rounds on ICU were conducted in most hospitals (99%, 146/148) most often daily on weekdays (47%). After ICU, the most common specialty ward rounds were in medicine (64%), followed by surgery (60%) and haematology (58%).
Antimicrobial stewardship scores
Assigned overall scores (maximum attainable score of 65), ranged from 20 to 63 with a median of 45 (IQR 39-51). The mean structure score was 14.6 (range 5-21) and the process score was 29.7 (range 8-44). There were no significant differences in total scores according to hospital type (P"0.121) or geographical region (P"0.679). The mean scores according to geographical region are shown in Figure 1 .
There was no association between structure scores and geographical region; however, there was a slightly higher mean structure score (16.1) for teaching hospitals compared with nonteaching hospitals (14.1) (P"0.068) and this was similar for specialist hospitals (14.2). There was no significant association found between process score and geographical region (P"0.881) or hospital type (P"0.541). There was a weak but positive correlation identified between overall structure and process scores (score: rho"0.206, P"0.012) as shown in Figure 3 .
Total antimicrobial prescribing and stewardship scores
Overall there was no significant change in mean total antimicrobial prescribing (IRR"1.02, 95% CI 1.00-1.05, P"0.116) between 2016 and 2017 for all participating NHS acute hospitals. Having a higher than average structure (15) or process (30) score was not separately associated with a change in total antimicrobial prescribing; although hospitals with higher structure scores tended to have lower baseline prescribing rates, this was not conclusive (IRR"0.86, 95% CI 0.72-1.03). Hospitals scoring low for both categories showed a 5% increase in total prescribing (IRR 1.05, 95% CI 1.00-1.11, P"0.042) between 2016 and 2017.
Hospitals that submitted CQUIN AMR data for both years showed some evidence, although this did not reach statistical significance, of having above average scores for structure (OR"1.89, 95% CI 0.87-4.10, P"0.109) and process (OR"2.18, 95% CI 0.99-4.81, P"0.054).
AWaRe categories of antimicrobial prescribing and stewardship scores
There were no major changes in the antimicrobials prescribed nationally in the combined AWaRe categories between 2016 and 2017 for all hospitals (Figure 4 ). There were no significant changes between 2016 and 2017 in prescribing from the 'Access' category by hospital type, geographical region or ASP score. For the 'Watch' Scobie et al. agent category, there was little difference in average baseline prescribing by hospital type. There was also little change between 2016 and 2017 for non-teaching hospitals (P"0.202) and teaching hospitals (P"0.982), but there was an increase in 'Watch' prescribing for specialist hospitals (OR"1.10, 95% CI 1.01-1.20). There was evidence of slightly higher, though not statistically significant, prescribing at baseline for the 'Watch' antimicrobial category if the structure score was above average (15) (OR"1.12, 95% CI 0.98-1.28).
For the 'Reserve' category, both the baseline rate and difference between 2016 and 2017 exhibited substantial variation, although much of the variability was due to several extreme outliers with very high initial proportions and large increases. Teaching hospitals prescribed more 'Reserve' category antimicrobials in 2017 compared with non-teaching hospitals (OR"1.58, 95% CI 1.23-3.02) although the greatest increase from 2016 to 2017 was seen in specialist hospitals (OR"3.09, 95% CI 2.02-4.74). A higher process score was associated with lower baseline prescribing of 'Reserve' category antimicrobials (OR"0.82, 95% CI 0.67-1.01). All other differences in baseline prescribing and changes over time were non-significant (P.0.35).
Focusing on carbapenem prescribing alone, total carbapenem prescribing rates declined by 7% between 2016 and 2017 (IRR"0.930, 95% CI 0.883-0.979, P"0.005). A higher than average process score was weakly associated with a greater decrease in carbapenem prescribing between 2016 and 2017 compared with lower than average scores (IRR"0.94, 95% CI 0.86-1.03, P"0.190) with all other associations having P values over 0.4. Antimicrobial stewardship: structure, process and outcomes
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Discussion
This study was designed to evaluate compliance with ASP practices according to current published standards using a scoring system and to examine total antimicrobial prescribing and prescribing using the England-modified WHO EML AWaRe categorization of antimicrobials as an outcome measure. 3, 8, 17 The majority of NHS trusts had embedded ASP structure components widely across their hospitals with the recognition of the pharmacist's role in antimicrobial stewardship as a major advance in England. Increased numbers of antimicrobial pharmacists have been employed since 2005; however, more needs to be done in providing dedicated financial support to ensure that the structure and processes are in place for sustainability of stewardship programmes. 18 Process-driven strategies such as controlled reporting of antimicrobial susceptibility test results to clinicians, based on local guidelines, and pre-authorization for certain antimicrobial agents were the most commonly utilized methods for reducing broadspectrum usage, with higher rates in our study compared with those reported globally. 19 Despite being labour intensive, they continue to be some of the most effective strategies at reducing inappropriate antimicrobial usage. 20 The most commonly restricted antimicrobials were fidaxomicin, tigecycline, daptomycin and linezolid plus some of the newer cephalosporin combination preparations (e.g. ceftolozane/tazobactam). Our findings differ from other studies where carbapenems and quinolones were the most commonly restricted antimicrobials; 19, 21 however, this may have been driven by cost-reducing measures, antimicrobial availability and patient population.
The frequency of antimicrobial ward rounds was variable; in almost all programmes a daily antimicrobial ward round was performed on weekdays on the ICU, which is similar to reported studies. 19 A systematic review showed ASP effects were approximately double in the ICU setting compared with other specialties; thus, in the presence of significant staff shortages and financial pressures, efforts could be focused in high prescribing areas and where they are likely to maximize stewardship effectiveness. 22 Our results also showed an increase in the use of prescribing policies, policy auditing and education of junior doctors compared with previous English studies. 23, 24 Identified process interventions requiring improvement included more regular distribution of local resistance surveillance data reports to staff (stratified by hospital department) and education of senior prescribers. Measuring the impact of stewardship programme activities is complex for a number of reasons including the range of simultaneous interventions, patient population heterogeneity, complex individual patient management and the need for labour-intensive outcome measures to evaluate the appropriateness of individual prescriptions. Assessment of direct patient outcome measures such as mortality, length of stay or infection-related re-admission rates may be influenced by these factors. 10, 25 Prevalence of healthcare-associated infection or of MDR organisms, such as ESBL producers, are also reported outcome measures; however, these too are influenced by related factors such as infection prevention control practices. 10, 25 Prescriber outcomes (such as behaviours and adherence) are alternative measures; however, these may not be useful in the short term to predict direct patient benefit. 10, 25 Prior to 2015, in England there was an upward trend in antimicrobial usage year on year; following implementation of CQUIN AMR targets, prescribing rates for 2016-17 showed a reduction. 16, 26 Carbapenem prescribing rates fell by 7% over the time period, which may be a response to the financial incentives provided for meeting carbapenem CQUIN AMR targets. It is important to note that CQUIN AMR targets are monitored by ASP teams in most English hospitals and achievement of CQUIN AMR targets could be a potential indicator of a successful programme.
We developed a scoring system to assess ASPs, to examine the relationship between structure and process, according to hospital type and geographical location, and to evaluate antimicrobial Antimicrobial stewardship: structure, process and outcomes JAC prescribing (total and by AWaRe category) as an outcome measure. To our knowledge this is the first report that has examined the association of an ASP and prescribing using the AWaRe categorization as an outcome.
We were committed to using 2016 as the baseline year for analysis of antimicrobial usage in the NHS as this was the first year of standardized quarterly CQUIN AMR data collection across NHS England. It was therefore not surprising that outcome measures linking stewardship scores with antimicrobial usage did not show large variations between 2016 and 2017. That teaching and specialist hospitals prescribed more 'Watch' and 'Reserve' categories of antimicrobial agents is also to be expected because of the complexity of the therapeutic interventions and the nature of the patients managed at these centres. It was notable, however, that there was a small but significant association between hospitals scoring low for both structure and process and an increase in total prescribing between 2016 and 2017. Results from a European survey have similarly demonstrated considerable variation in stewardship practices across countries but no significant difference in stewardship indicators except a non-significant trend for lower antimicrobial use. 27 We contend that other indices that did not show statistical significance are worth mentioning and need to be monitored over time to ascertain their significance. Notably, the observed, albeit non-significant, trend towards higher baseline 'Watch' prescribing if the structure score was above average and a lower baseline 'Reserve' prescribing with a high process score, could both be indicators of institutional culture, commitment and leadership. We postulate that these and related indices could be useful to discriminate between strong and weak ASPs, using our scoring system, if re-examined over an extended period of time.
Limitations
Although stewardship leads were requested to complete the survey, this did not occur unanimously, and some respondents may have had more limited knowledge of their respective ASPs. There was no system of clarifying survey responses and the interpretation of questions could not be standardized; thus, responder subjectivity and self-reporting biases may have been confounders in this study. A combination of these factors could account for the wide variation seen in scores between trusts; however, every question had a comments box and all comments were scrutinized for potential ambiguities in interpretation and clarification sought from responders. In cases of duplicate responses, minor score discrepancies were identified; however, the original respondents were always approached to clarify answers and scores were readjusted. Such discrepancies would have been missed for trusts submitting a single response. Responses were missing from four hospitals, which may be a reflection of their stewardship capabilities; however, our study had a high response rate compared with previous studies and, therefore, this is unlikely to have had a significant impact. 21, 24, 28 The scoring system developed for this analysis did not undergo formal validation but was based on previously published, validated scoring systems. Scores were modelled on the assumption that well-resourced components were likely to be associated with higher quality interventions; however, they may not have always correlated. The shortage of piperacillin/tazobactam in 2017 meant that usage in England was restricted at the time of the study, which may have confounded the results of prescribing from the other categories. Total antimicrobial usage data for hospitals also included OPAT usage data which may have increased the proportions of 'Reserve' category antimicrobials (with pharmacokinetics favouring once-daily dosing with agents such as ceftriaxone or ertapenem) prescribed in some specialist or teaching hospitals with large OPAT services.
Analysing antimicrobial usage data over a 1year period would not have been sufficient to detect significant changes resulting from recent stewardship interventions, especially in hospitals with long-established, effective ASPs that are unlikely to show substantial changes year on year. Our analysis was also hampered by high levels of variability in prescribing between hospitals; this may be because some hospitals had a more complex case mix although the exact cause of the variability remains unknown.
Long-term strategies such as education, audit and feedback may take years to effect notable changes in prescribing behaviours. The baseline year of 2016 was, however, a significant timepoint in the landscape of antimicrobial usage data collection and therefore the most appropriate baseline year for analysis.
Future work and conclusions
This study highlights important findings about ASPs in NHS acute hospitals in England and associated antimicrobial prescribing. It demonstrates that a majority of NHS acute hospitals in England have achieved significant progress with their ASPs compared with previous surveys, 4 and implementation is broadly consistent irrespective of hospital type or geographical region. This indicates that within the NHS an appropriate ASP is recognized as best practice for patient care.
As part of the study, we developed a scoring system to evaluate the effectiveness of ASPs in England, assessing two main components, structure and process, and comparing this with antimicrobial prescribing data between the 2016 baseline and 2017 using both total and AWaRe prescribing as outcomes. Although there was no significant correlation between stewardship scores and overall antimicrobial usage within hospitals there were some noteworthy associations. Hospitals scoring low for both structure and process showed a significant increase in total prescribing between 2016 and 2017. A trend towards higher baseline 'Watch' prescribing with an above average structure score or lower baseline 'Reserve' prescribing associated with a high process score, albeit both non-significant, could be more informative when re-analysed over time. We suggest that our ASP quality indicators and scoring system together with a total and AWaRe prescribing outcome measure could be modified to suit different settings and be used to evaluate the effectiveness of an ASP or to discriminate between high-and low-performance ASPs. Monitoring prescriptions within the modified AWaRe categories is already being used nationally as a quality indicator within the 2018/19 CQUIN AMR analysis. Further studies are needed with better defined primary outcomes such as burden of disease or attributable mortality due to antimicrobial resistance to assess the true impact of programme interventions over time. 29 This may become easier with more widespread use of electronic prescribing, electronic patient records and the inclusion of drug-resistant infection as part of certification as a cause of mortality.
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